Guanhao Biotech Co.,Ltd.
SHZ: 300238.SZ0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Shenzhen Stock Exchange
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Feng Zhao
- Employees
- 535
- Headquarters
- Guangzhou, China
- IPO year
- 2011
- Market cap
- CN¥3.8B
- Website
- https://www.guanhaobio.com
Loading 300238…
Loading profile data…Frequently asked questions about 300238
What does Guanhao Biotech Co.,Ltd. (300238.SZ) do?
Guanhao Biotech Co.,Ltd. develops, manufactures, and markets regenerative medicine in China. It offers NormalGEN, a type of biological dura repair patch manufactured from animal tissue; GrandNeuro, an artificial dura patch for dura repairing; ThormalGEN, a biological surgical patch manufactured from animal tissue for surgical repairs; DermalGEN,...
Where does 300238.SZ trade?
Guanhao Biotech Co.,Ltd. (300238.SZ) trades on the Shenzhen Stock Exchange.
What sector is 300238.SZ in?
Guanhao Biotech Co.,Ltd. (300238.SZ) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Guanhao Biotech Co.,Ltd.?
Feng Zhao is the chief executive officer of Guanhao Biotech Co.,Ltd. (300238.SZ).
Where is Guanhao Biotech Co.,Ltd. headquartered?
Guanhao Biotech Co.,Ltd. is headquartered in China.
Does 300238.SZ pay a dividend?
Guanhao Biotech Co.,Ltd. (300238.SZ) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did 300238.SZ go public?
Guanhao Biotech Co.,Ltd. (300238.SZ) completed its initial public offering in 2011.